Mount Sinai Innovation Partners
Est. dry powder
$80K
Raised, not yet invested
AUM
—
Not reported
Latest fund
$10M
i3 Accelerator
Est. cheque size
$100K–
From fund sizes
Deals, last 12 months
—
Not reported
About Mount Sinai Innovation Partners
Based in the US, Mount Sinai Innovation Partners is a private equity firm that facilitates real-world application and commercialization of discoveries and innovation of healthcare products and services that benefit patients and society across the US. The firm operates as subsidiary of Mount Sinai Health System, Inc.
- Type
- Venture Capital Firm
- Headquarters
- New York, New York, US
- Stages
- SeedSeries ASeries B
- Est. cheque size
- $100K–$500K
- Sectors
- Healthcare, Information Technology
- Regions
- North America
- Strategies
- Pre-Seed, Seed, Series A
Where they invest
From deals and portfolio companies on record
Most frequent rounds
- Series A3
- Series B2
- Seed1
Across 6 deals
Portfolio sectors
- Software2
- Biotechnology1
- Healthcare IT1
- Internet1
- Travel & Leisure1
Across 6 companies
Portfolio countries
- Singapore3
- US3
Across 6 companies
Recent investments
Newest 5 of 6
- Series A$3.9M
Epitome Global Pte. Ltd.
Jan 2022 · Series A
- Series B$67.4M
HiberCell, Inc.
May 2021 · Series B
- Series B$2M
Jump Technologies, Inc.
Nov 2018 · Series B
- Seed$1.8M
Rx.Health, Inc.
Aug 2018 · Seed
- Series A$1.9M
GlobalTix Pte Ltd
Aug 2016 · Series A
Offices
1 location
- New York, New York, USHQ
Questions about Mount Sinai Innovation Partners
How much does Mount Sinai Innovation Partners invest per deal?
Based on the size of its funds, Mount Sinai Innovation Partners writes estimated cheques of $100K–$500K. Lead cheques usually sit at the top of that range and follow-on cheques lower.
What stages does Mount Sinai Innovation Partners invest in?
Mount Sinai Innovation Partners has invested at Seed, Series A and Series B. Its most frequent rounds on record are Series A, Series B and Seed.